Universitätsklinikum Hamburg-Eppendorf (UKE) — Klinik für Psychiatrie und Psychotherapie, Spezialambulanz für Neuromodulation

Treatment & access

• Treatments offeredEsketamine nasal spray (Spravato®)
• Access routeCovered by a national programme
• Cost & coverage (registry status)Covered by GKV for on-label TRD; see country guide
• ReimbursementGKV: Praxisbesonderheit (outpatient) / hospital financing (inpatient) How reimbursement works in Europe →
• Phone+49 40 7410-53210
• Websitehttps://www.uke.de/kliniken-institute/kliniken/psychiatrie-und-psychotherapie/behandlungsangebot/ambulante-angebote/

About this provider

University Medical Center Hamburg-Eppendorf (UKE) is a major German university hospital. Its Department of Psychiatry and Psychotherapy runs a special outpatient clinic for neuromodulation whose official patient flyer, published on the UKE domain, states that outpatient therapy with nasal esketamine is available, alongside nasal or intravenous ketamine therapy in day-clinic or inpatient settings in cooperation with ward P3. The offering sits within a portfolio that also includes ECT and rTMS.

Practical details

As stated on the provider's own website (checked 2026-09-22); details can change — confirm when you book.

• Opening hoursNotfallsprechzeiten: Mo–Fr 08:30–12:00 Source →
• BookingReferral required — the provider states access runs via a clinician's referral. Source →

Common questions

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.